177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-7364
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT ; volume:9 ; number:1 ; day:3 ; month:5 ; year:2022 ; pages:1-16 ; date:12.2022
EJNMMI Physics ; 9, Heft 1 (3.5.2022), 1-16, 12.2022
- Urheber
-
Mazzara, Christophe
Salvadori, Julien
Ritzenthaler, Florian
Martin, Simon
Porot, Clémence
Imperiale, Alessio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-022-00466-y
- URN
-
urn:nbn:de:101:1-2022071120123560016555
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mazzara, Christophe
- Salvadori, Julien
- Ritzenthaler, Florian
- Martin, Simon
- Porot, Clémence
- Imperiale, Alessio
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC](/assets/placeholder/searchResultMediaUnknown.png)
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
177Lu-DOTA-Octreotat bei Radiorezeptortherapie neuroendokriner Tumore: intratherapeutische Dosimetrie und Eliminationskinetik
Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
The effects of temperament type on infusion extravasation in newborns
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Fernmetastasierte neuroendokrine Tumoren des Pankreas: Ansprechen auf Radiopeptidtherapie mit 177Lu-DOTA-Octreotat
Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
177Lu-DOTA-Octreotat bei Radiorezeptortherapie neuroendokriner Tumore: intratherapeutische Dosimetrie und Eliminationskinetik
Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
The effects of temperament type on infusion extravasation in newborns
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Fernmetastasierte neuroendokrine Tumoren des Pankreas: Ansprechen auf Radiopeptidtherapie mit 177Lu-DOTA-Octreotat
Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
177Lu-DOTA-Octreotat bei Radiorezeptortherapie neuroendokriner Tumore: intratherapeutische Dosimetrie und Eliminationskinetik
Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
The effects of temperament type on infusion extravasation in newborns
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Fernmetastasierte neuroendokrine Tumoren des Pankreas: Ansprechen auf Radiopeptidtherapie mit 177Lu-DOTA-Octreotat